Twenty-year Follow-up of the Inter99 Cohort
Launched by BISPEBJERG HOSPITAL · Dec 20, 2021
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
BACKGROUND Type 2 Diabetes (T2D) affecting globally more than 400 million people represents one of the most significant global health challenges of our time. However, despite huge research investments, there are still limited insights into its complicated etiology and pathophysiology during the life-course. T2D is furthermore defined by arbitrary glycemic thresholds, which inadequately captures the diversity of clinical presentations and sub-phenotypes with differential complications and damages in multiple organs including small and large vessels, heart, kidney, liver and nerve tissue, oft...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have participated in the Inter99 Baseline examination.
- Exclusion Criteria:
- • Physically or cognitively unable to participate in the 3-hour clinical follow-up study.
About Bispebjerg Hospital
Bispebjerg Hospital is a leading healthcare institution located in Copenhagen, Denmark, renowned for its commitment to innovative medical research and clinical excellence. As a key sponsor of clinical trials, the hospital focuses on advancing healthcare by exploring novel therapies and treatment protocols across various medical disciplines. With a multidisciplinary team of experienced researchers and clinicians, Bispebjerg Hospital aims to enhance patient outcomes through rigorous scientific inquiry and evidence-based practices, while fostering collaboration with academic institutions and industry partners to drive progress in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, , Denmark
Patients applied
Trial Officials
Allan A Vaag, D.M.Sc/D.Sc
Principal Investigator
Steno Diabetes Center Copenhagen, The Capital Region of Denmark
Allan Linneberg, PhD
Study Chair
Center for Clinical Research and Prevention, The Capital Region of Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials